{ China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint...

15
{ China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013

Transcript of { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint...

Page 1: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

{

China’s Health Transitions

Diseases of poverty and affluence

Tina Phillips Johnson, PhDSaint Vincent CollegeOctober 27, 2013

Page 2: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

Medical transitions are changes in the field of medicine.

Health transitions are changes in the health of populations.

Comprised of: Demographic transition: patterns of

fertility and mortality Epidemiologic transition: patterns of

disease

Health transitions

Page 3: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

Direct health action Traditional and modern medicine Medical systems

Social determinants of health Political stability Economic growth Literacy Education

Health transitions shaped by:

Page 4: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

Data sources are variable by time and place

Insufficient transparency National-level focus Skewed data

Disease epidemics Invasion, war, conflict Famine

Problems with data

Page 5: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

Population tripled in 20th century Estimated 430 million 1900; 1.3 billion

2000 Birth and death rates dropped 1950-2000 Population policy 1970-79:

Voluntary “late, long, few” policy Fertility rate halved from 5.2 to 2.9

Due to: Universal education Improved child survival Greater gender equality

China’s 20th-century demographic transition

Wang 2011

Page 6: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

Skewed sex ratio 1.06 in 1979 1.11 in 1988 1.17 in 2001

Problems? Trafficking of girls Commercial sex work industry STDs

Demographics (cont.)

Davin 2007

Page 7: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

Aging population 5% >65 years in 1982 7.5% >65 years in 2012 >65 expected to rise to more than 15% by

2025

Rural-urban migration 12% urban in 1950 50% urban in 2012

Demographics, cont.

Davin, 2007

Page 8: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

Figure 3 – Age structure of China (1950, 2010, 2050)

Source:(United Nations 2011)

Page 9: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

Shifts in burden of disease

High fertility, high mortality (pre-transition)

Characterized by infectious disease High fertility, low mortality (transition)

Medical advances prolong life expectancy Low fertility, low mortality (post-

transition) Increased life expectancy, medical

advances, chronic disease

Epidemiologic Transition

Omran 1970

Page 10: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

1950

1960

1970

1976

1978

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

2002

2004

2006

2008

0

5

10

15

20

25

30

35

40

0

0.05

0.1

0.15

0.2

0.25

0.3

0.35

0.4

0.45

0.5

Crude Birth Rate Crude Death Rate % urban population

One child policy

Crude birth rate (‰), crude death rate (‰) and % urban population

Chen 2013

Page 11: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.
Page 12: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

Africa East MED SEA Europe Americas Western Pacific

0

100

200

300

400

500

600

0

10

20

30

40

50

60

70

80

49

62 6367

7171

Communicable diseases NCDsInjuries Life Expectancy

Burden of Disease (DALYs) in world regions, 2004(Low- and middle- income countries grouped by WHO region, 2004)

DALY: Disease-adjusted life year; The overall disease burden, expressed as the number of years lost due to ill-health, disability or early death.

Page 13: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

China’s double burden of disease

Infectious diseases and epidemics Chronic and man-made non-communicable

diseases

Page 14: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

Questions?

Page 15: { China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.

Works Cited

Chen L. China’s Exceptional Health Transitions: Overcoming the Four Horsemen of Apocalypse. 2011.

Davin D. Marriage Migration in China and East Asia. J Contemp China. 2007;16(50):83–95.

Ho CS, Gostin LO. The Social Face of Economic Growth: China’s Health System in Transition. JAMA. 2009;301(17):1809–11. 

Liu Y, Yang G, Zeng Y, Horton R, Chen L. Policy dialogue on China’s changing burden of disease. The Lancet. 2013;381:1961–62.

Omran, AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Memorial Fund Quarterly. 1970; 49.4:509-38.

Wang F. The Future of a Demographic Overachiever: Long-Term Implications of the Demographic Transition in China. Popul Dev Rev. 2011;37 (Supplement):173–90.

Yang G, Zeng Y, Gao GF, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. The Lancet. 2013;381:1987–2015.